Orano Med
Hérico TSARALAZA is a skilled supply operations and projects engineer at Orano Med since October 2017, with responsibilities including HSE correspondence, project management for Med facilities in Bessines, operational support for maintenance and construction, and industrial design using AutoCAD and SolidWorks. Hérico also focuses on supply chain development for nuclear goods and has prior experience as a geophysicist apprentice at Total, where seismic data exploitation was a key task. Early career roles included positions as an etiquette and fabrication operator at Delpeyrat. Hérico holds a diploma in industrial engineering from École des Mines de Saint-Étienne and multiple qualifications in physics and mechanical engineering from IUT institutions.
This person is not in any offices
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.